Elaine Ullian Net Worth

The estimated Net Worth of Elaine Ullian is at least $18 Milion dollars as of 13 November 2017. Ms. Ullian owns over 12,774 units of Thermo Fisher Scientific stock worth over $16,885,195 and over the last 21 years she sold TMO stock worth over $773,355. In addition, she makes $341,266 as Independent Director at Thermo Fisher Scientific.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ms. Ullian TMO stock SEC Form 4 insiders trading

Elaine has made over 40 trades of the Thermo Fisher Scientific stock since 2004, according to the Form 4 filled with the SEC. Most recently she exercised 12,774 units of TMO stock worth $240,407 on 13 November 2017.

The largest trade she's ever made was exercising 55,000 units of Thermo Fisher Scientific stock on 15 November 2005 worth over $604,450. On average, Elaine trades about 4,031 units every 40 days since 2003. As of 13 November 2017 she still owns at least 27,302 units of Thermo Fisher Scientific stock.

You can see the complete history of Ms. Ullian stock trades at the bottom of the page.

Elaine Ullian biography

Elaine S. Ullian is Independent Director of the Company. She was the President and Chief Executive Officer of Boston Medical Center, a 550-bed academic medical center affiliated with Boston University, from July 1996 to her retirement in January 2010. Ms. Ullian is also a director of Vertex Pharmaceuticals, Inc. and Hologic Inc.

What is the salary of Elaine Ullian?

As the Independent Director of Thermo Fisher Scientific, the total compensation of Elaine Ullian at Thermo Fisher Scientific is $341,266. There are 16 executives at Thermo Fisher Scientific getting paid more, with Marc Casper having the highest compensation of $19,023,100.

How old is Elaine Ullian?

Elaine Ullian is 71, she's been the Independent Director of Thermo Fisher Scientific since 2001. There are no older and 25 younger executives at Thermo Fisher Scientific.

What's Elaine Ullian's mailing address?

Elaine's mailing address filed with the SEC is 35 CROSBY DRIVE, , BEDFORD, MA, 01730.

Insiders trading at Thermo Fisher Scientific

Over the last 21 years, insiders at Thermo Fisher Scientific have traded over $356,502,416 worth of Thermo Fisher Scientific stock and bought 4,301 units worth $223,007 . The most active insiders traders include Thomas J Lynch, Dion J Weisler oraz Marc N Casper. On average, Thermo Fisher Scientific executives and independent directors trade stock every 23 days with the average trade being worth of $16,400,322. The most recent stock trade was executed by Marc N Casper on 3 September 2024, trading 20,000 units of TMO stock currently worth $4,213,600.

What does Thermo Fisher Scientific do?

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. 

Complete history of Ms. Ullian stock trades at Hologic, Vertex Pharmaceuticals oraz Thermo Fisher Scientific

Thermo Fisher Scientific executives and stock owners

Thermo Fisher Scientific executives and other stock owners filed with the SEC include:

• Marc Casper,
  Chairman of the Board, President, Chief Executive Officer
• Marc N. Casper,
  Chairman, Pres & CEO
• Mark Stevenson,
  Chief Operating Officer, Executive Vice President
• Michel Lagarde,
  Executive Vice President
• Stephen Williamson,
  Chief Financial Officer, Senior Vice President
• Mark P. Stevenson,
  Exec. VP
• Syed Jafry,
  Senior Vice President and President, Regions
• Stephen Williamson,
  Sr. VP & CFO
• Syed A. Jafry,
  Sr. VP & Pres of Regions
• Gianluca Pettiti,
  Exec. VP
• Jim Manzi,
  Independent Director
• Nelson Chai,
  Independent Director
• Judy Lewent,
  Independent Director
• Tyler Jacks,
  Independent Director
• Thomas Lynch,
  Lead Independent Director
• Scott Sperling,
  Independent Director
• Elaine Ullian,
  Independent Director
• Lars Sorensen,
  Independent Director
• C. Martin Harris,
  Independent Director
• Dion Weisler,
  Independent Director
• James Mullen,
  Independent Director
• Debora Spar,
  Independent Director
• R. Alexandra Keith,
  Director
• Kenneth Apicerno,
  Vice President- Investor Relations
• Peter Hornstra,
  Vice President, Chief Accounting Officer
• Michael Boxer,
  Senior Vice President, General Counsel
• Sandy B. Pound,
  VP & Chief Communications Officer
• Michael A. Boxer Esq.,
  Sr. VP & Gen. Counsel
• Rafael Tejada,
  VP of Investor Relations
• Dr. Karen E. Nelson Ph.D.,
  Chief Scientific Officer
• Ryan J. Snyder,
  Sr. VP & Chief Information Officer
• Joseph R. Holmes,
  VP & Chief Accounting Officer
• William G Parrett,
  Director
• Daniel P Shine,
  Senior Vice President
• Thomas W Loewald,
  Senior Vice President
• Seth H Hoogasian,
  VP, Gen. Counsel & Secretary
• Patrick M Durbin,
  Senior Vice President
• Gregory J. Herrema,
  Senior Vice President
• Andrew J Thomson,
  Senior Vice President
• Edward A Pesicka,
  Senior Vice President
• Alan J Malus,
  Senior Vice President
• Kenneth Berger,
  Senior Vice President
• Michael E Porter,
  Director
• Peter J Manning,
  Director
• Yuh Geng Tsay,
  Senior Vice President
• Stephen P Kaufman,
  Director
• Michael Adam Bell,
  Director
• Bruce L Koepfgen,
  Director
• Stephen G Sheehan,
  VP, Human Resources
• Marijn E Dekkers,
  Chief Executive Officer
• Fredric T Walder,
  Sr. VP, Commercial Excellence
• Peter M Wilver,
  VP, Financial Operations
• Guy Broadbent,
  VP, Optical Technologies
• Alexander G Stachtiaris,
  Sr. VP, Global Bus. Services
• Joseph R Massaro,
  Sr. VP, Global Bus. Services
• Paul M Meister,
  Director
• Robert A Mccabe,
  Director
• Leary Robert O,
  Director
• John L Lamattina,
  Director
• Kyriazi Theo Melas,
  VP & Chief Financial Officer
• Richard F/Ca Syron,
  Executive Chairman
• Barry S Howe,
  VP, Measurement & Control
• Joseph R. Holmes,
  VP & Chief Accounting Officer
• Gianluca Pettiti,
  Executive Vice President
• Ruby R Chandy,
  Director
• Lisa P. Britt,
  Sr. VP and Chief HR Officer
• Jennifer M Johnson,
  Director
• Michael D Shafer,
  Executive Vice President
• Frederick M. Lowery,
  Executive Vice President